Dr. Lal PathLabs Limited (LALPATHLAB.NS) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-26). See the full ratio breakdown and business-activity screen below for the reasoning.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2026-03-31. LALPATHLAB.NS files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.25% | 30.00% | Pass |
| Interest-bearing investments | 4.18% | 30.00% | Pass |
| Non-permissible income | 2.43% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 12.65% | 33.00% | Pass |
| Interest-bearing investments | 42.30% | 33.00% | Fail |
| Non-liquid assets | 54.18% | at least 20.00% | Pass |
| Non-permissible income | 2.43% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 12.65% | 33.33% | Pass |
| Cash + interest-bearing securities | 42.30% | 33.33% | Fail |
| Accounts receivable | 45.82% | 33.33% | Fail |
| Non-permissible income | 2.43% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 12.65% | 33.33% | Pass |
| Cash + interest-bearing securities | 42.30% | 33.33% | Fail |
| Accounts receivable | 45.82% | 50.00% | Pass |
| Non-permissible income | 2.43% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.58% | 33.00% | Pass |
| Cash + interest-bearing securities | 5.30% | 33.00% | Pass |
| Accounts receivable | 0.44% | 33.00% | Pass |
| Non-permissible income | 2.43% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.68% | 33.00% | Pass |
| Cash + interest-bearing securities | 5.61% | 49.00% | Pass |
| Accounts receivable | 0.47% | 49.00% | Pass |
| Non-permissible income | 2.43% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.68% | 33.33% | Pass |
| Cash + interest-bearing securities | 5.61% | 33.33% | Pass |
| Accounts receivable | 6.08% | 49.00% | Pass |
| Non-permissible income | 2.43% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 53.60 | NEUTRAL |
| Stochastic %K (14) | 49.67 | NEUTRAL |
| CCI (20) | 0.43 | NEUTRAL |
| Williams %R (14) | -50.33 | NEUTRAL |
| MACD (12,26,9) | -7.22 | SELL |
| ROC (10) | -1.42 | SELL |
| Momentum (10) | -27.40 | SELL |
| EMA (10) | 1912.59 | SELL |
| SMA (10) | 1914.68 | SELL |
| EMA (20) | 1905.15 | BUY |
| SMA (20) | 1909.19 | SELL |
| EMA (30) | 1886.73 | BUY |
| SMA (30) | 1915.04 | SELL |
| EMA (50) | 1839.80 | BUY |
| SMA (50) | 1839.06 | BUY |
| EMA (100) | 1741.10 | BUY |
| SMA (100) | 1711.10 | BUY |
| EMA (200) | 1633.33 | BUY |
| SMA (200) | 1557.67 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Diagnostics & Research
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.